American Heart Journal
Volume 152, Issue 3 , Pages 417-419 , September 2006

The blood pressure measurement—revisited

  • Michel E. Safar, MD

      Affiliations

    • Hopital Hotel Dieu, Paris, France
    • ,
  • Harold Smulyan, MD, FACC

      Affiliations

    • State University of New York, Upstate Medical University, Syracuse, NY
    • Corresponding Author InformationReprint requests: Harold Smulyan MD, Department of Medicine, State University of New York, Upstate Medical University, 750 E. Adams St, Syracuse, NY 13210.

Received 3 October 2005 ,Accepted 20 March 2006.

References 

  1. American National Standard for Electronic or Automated Sphygmomanometers . ANSI/AAMI SP10-1992. In: Arlington (VA): Association for the Advancement of Medical Instrumentation; 1993;p. 12
  2. Nichols WW, O'Rourke M. Chapter 9—contours of pressure and flow waves in arteries. In: McDonald's blood flow in arteries. Theoretical, experimental and clinical principles. 5th Ed.. London: Arnold E; 2005;p. 166–191
  3. Dahlöf B, Devereux RB, Kjeldsen SE, et al. LIFE Study Group Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995–1003
  4. Devereux RB, Dalhof B, Gerdts E, et al. Regression of left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial. Circulation. 2004;110:1456–1462
  5. Morgan T, Lauri J, Bertram D, et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118–123
  6. Asmar RG, London GM, O'Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension. 2001;38:922–926
  7. Hirata K, Vlachopoulos C, Adji A, et al. Benefits from angiotensin-converting enzyme inhibitor “beyond blood pressure lowering”: beyond blood pressure or beyond the brachial artery?. J Hypertens. 2005;23:551–556
  8. de Luca N, Asmar RG, London GM, et al. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623–1630
  9. Nakayama Y, Tsumura K, Yamashita N, et al. Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation. 2000;101:470–472
  10. Nishijima T, Nakayama Y, Tsumura K, et al. Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease. Am J Hypertens. 2001;14:469–473
  11. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735–738
  12. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531–536
  13. van Montfrans GA. Oscillometric blood pressure measurement: progress and problems. Blood Press Monit. 2001;6:287–290
  14. Baker PD, Westenskow DR, Kuck K. Theoretical analysis of non-invasive oscillometric maximum amplitude algorithm for estimating mean blood pressure. Med Biol Eng Comput. 1997;35:271–278
  15. Benjamin EJ, Larson MG, Keyes KJ, et al. clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation. 2004;109:613–619
  16. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial—Blood Pressure Lowering Arm (ASCOT-BPLA): a Multicentre Randomised Controlled Trial. Lancet. 2005;366:895–906
  17. Williams B, Lacy PS, Thorn SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation. 2006;113:1213–1225

PII: S0002-8703(06)00259-6

doi: 10.1016/j.ahj.2006.03.016

American Heart Journal
Volume 152, Issue 3 , Pages 417-419 , September 2006

Article Tools